Chemours Company (The)

Chemours Company (The)

11.86
EUR
-0.32
(-2.63%)
-1.76EPS
Feb 11Next Earn

Important Dates

Chemours Co.'s next confirmed earnings release is scheduled for February 11, 2027.

Earnings Date2/11/2027

Share Statistics

As of June 30, 2026, Chemours Co. has 150.46M shares outstanding.

Shares Outstanding150.46M

Financial Position

As of June 30, 2026, Chemours Co. maintains a current ratio of 1.66, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -8,583.33, indicating conservative leverage, while an interest coverage ratio of 1.75 demonstrates limited ability to service its debt obligations.

Current Ratio1.66
Quick Ratio0.85
Debt / Equity-8,583.33
Debt / EBITDA8.62
Interest Coverage1.75

Financial Efficiency

EUR

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -4.15, reflecting losses generated across the asset base. The company generates approximately 878,634.48 in revenue per employee across its workforce of 5,775.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.26 indicates how many times Chemours Co. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-4.15
Revenue Per Employee878,634.48
Employee Count5,775.00
Inventory Turnover3.26

Taxes

EUR

Over the twelve months ended June 30, 2026, Chemours Co. recorded 232.83M in income tax expense. The company reported a pretax loss of -34.14M and -266.09M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax232.83M

Income Statement

EUR

Over the twelve months ended June 30, 2026, Chemours Co. generated 5.07B in revenue and converted that into -266.09M in net income, yielding earnings per share of -1.76. EBITDA reached 418.39M, while operating income came in at -72.65M.

Revenue5.07B
Gross Profit776.39M
Operating Income-72.65M
Pretax Income-34.14M
Net Income-266.09M
EBITDA418.39M
EBIT139.17M
Earnings Per Share (EPS)-1.76

Balance Sheet

EUR

As of June 30, 2026, Chemours Co. holds 587.33M in cash and equivalents against 3.61B in total debt, resulting in a net debt position of 2.80B. Total book value stands at -42.89M, with working capital of 1.08B providing operational flexibility.

Cash & Cash Equivalents587.33M
Total Debt3.61B
Net Debt2.80B
Equity (Book Value)-42.89M
Book Value Per Share-0.29
Working Capital1.08B

Cash Flow

EUR

Chemours Co. produced 347.49M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -156.68M in capital expenditures, free cash flow totaled 190.82M - equivalent to 1.27 per share.

Operating Cash Flow347.49M
Capital Expenditures-156.68M
Free Cash Flow190.82M
FCF Per Share1.27

Margins

Over the twelve months ended June 30, 2026, Chemours Co. posted a gross margin of 15.30, reflecting its pricing power and cost economics. The operating margin of -1.43 and net profit margin of -5.24 provide insight into operational efficiency.

Gross Margin15.30
Operating Margin-1.43
Pretax Margin-0.67
Profit Margin-5.24
EBITDA Margin8.25

Dividends & Yields

EUR

Over the twelve months ended June 30, 2026, Chemours Co. paid dividends of 0.31 per share. The dividend payout ratio of -17.65 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth.

Dividend Per Share0.31
Payout Ratio-17.65